Literature DB >> 1434516

Serum selenium levels in individuals on PKU diets.

G Darling1, P Mathias, M O'Regan, E Naughten.   

Abstract

Serum selenium levels in 73 patients with phenylketonuria were significantly lower than in controls. The phenylketonuric and hyperphenylalaninaemic individuals taking the non-supplemented amino acid mixture generally had lower levels: 36% were below the normal range as defined by our laboratory, compared with 19% in the supplemented group. The low levels were present even in those on diet, who had a greater phenylalanine tolerance--that is, a tolerance for more than 9 x 50 mg phenylalanine exchanges per day, in other words a higher intake of natural protein. Individuals on long-term synthetic diets may be at risk for selenium deficiency even on selenium supplements. In areas where the soil may be low in selenium, the deficiency may be aggravated. Long-term low levels may impair health but the required amount of selenium supplementation remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1434516     DOI: 10.1007/bf01800019

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  11 in total

1.  Selenium deficiency in total parenteral nutrition.

Authors:  A M van Rij; C D Thomson; J M McKenzie; M F Robinson
Journal:  Am J Clin Nutr       Date:  1979-10       Impact factor: 7.045

Review 2.  Nutritional influence on cellular antioxidant defense systems.

Authors:  C K Chow
Journal:  Am J Clin Nutr       Date:  1979-05       Impact factor: 7.045

3.  Analysis of selenium content in commercial dietetic products.

Authors:  K R O'Sullivan; P M Mathias
Journal:  Eur J Clin Nutr       Date:  1990-03       Impact factor: 4.016

4.  Trace elements nutriture in hyperphenylalaninemic patients. Long-term follow up study.

Authors:  R Longhi; A Rottoli; A Vittorelli; G Zecchini; T Bonabitacola; F Bertassi; E Riva; M Giovannini
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

5.  Trace elements in human health with special reference to selenium.

Authors:  A T Diplock
Journal:  Am J Clin Nutr       Date:  1987-05       Impact factor: 7.045

6.  Acute selenium poisoning.

Authors:  R F Carter
Journal:  Med J Aust       Date:  1966-03-26       Impact factor: 7.738

7.  Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study.

Authors:  J T Salonen; G Alfthan; J K Huttunen; J Pikkarainen; P Puska
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

8.  Selenium content of tissues in Finnish infants and adults with various diseases, and studies on the effects of selenium supplementation in neuronal ceroid lipofuscinosis patients.

Authors:  T Westermarck
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-08

9.  Serum-selenium concentrations in patients with maple-syrup-urine disease and phenylketonuria under dieto-therapy.

Authors:  I Lombeck; K Kasperek; L E Feinendegen; H J Bremer
Journal:  Clin Chim Acta       Date:  1975-10-01       Impact factor: 3.786

10.  Studies in human lactation: zinc, copper, manganese and chromium in human milk in the first month of lactation.

Authors:  C E Casey; K M Hambidge; M C Neville
Journal:  Am J Clin Nutr       Date:  1985-06       Impact factor: 7.045

View more
  9 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials.

Authors:  A P Prince; M P McMurray; N R Buist
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

3.  Investigation of oxidative stress parameters in treated phenylketonuric patients.

Authors:  A Sitta; A G Barschak; M Deon; T Terroso; R Pires; R Giugliani; C S Dutra-Filho; M Wajner; C R Vargas
Journal:  Metab Brain Dis       Date:  2006-12-05       Impact factor: 3.584

4.  Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.

Authors:  Carolina G Fernandes; Guilhian Leipnitz; Bianca Seminotti; Alexandre U Amaral; Angela Zanatta; Carmen R Vargas; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2009-09-23       Impact factor: 5.046

5.  Nutrition in Pediatric Cardiomyopathy.

Authors:  Tracie L Miller; Daniela Neri; Jason Extein; Gabriel Somarriba; Nancy Strickman-Stein
Journal:  Prog Pediatr Cardiol       Date:  2007-11

6.  Classical maple syrup urine disease and brain development: principles of management and formula design.

Authors:  Kevin A Strauss; Bridget Wardley; Donna Robinson; Christine Hendrickson; Nicholas L Rider; Erik G Puffenberger; Diana Shellmer; Diana Shelmer; Ann B Moser; D Holmes Morton
Journal:  Mol Genet Metab       Date:  2010-01-12       Impact factor: 4.797

7.  Long-term compliance with a novel vitamin and mineral supplement in older people with PKU.

Authors:  A MacDonald; P Lee; P Davies; A Daly; M Lilburn; H Gokmen Ozel; M A Preece; C Hendriksz; A Chakrapani
Journal:  J Inherit Metab Dis       Date:  2008-10-22       Impact factor: 4.982

8.  Nutritional status of patients with phenylketonuria in Japan.

Authors:  Yoshiyuki Okano; Toshikazu Hattori; Hiroki Fujimoto; Kaori Noi; Miki Okamoto; Toshiaki Watanabe; Ryoko Watanabe; Rika Fujii; Tomoko Tamaoki
Journal:  Mol Genet Metab Rep       Date:  2016-08-20

9.  The cardiovascular phenotype of adult patients with phenylketonuria.

Authors:  Aline Azabdaftari; Markus van der Giet; Mirjam Schuchardt; Julia B Hennermann; Ursula Plöckinger; Uwe Querfeld
Journal:  Orphanet J Rare Dis       Date:  2019-09-06       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.